| Janssen-Cilag AG - Zavesca, Kapseln | | 56898 | | 01 | | Zavesca | | Kapseln | | A16AX06 | | Miglustat | | 22.10.2004 | | |
| | Composition | | miglustatum 100 mg, carboxymethylamylum natricum A, povidonum K 30, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: E 172 (nigrum), lacca, pro capsula corresp. natrium 190 µg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Miglustate | 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Miglustate | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Carboxymethylamylum Natricum A | | | | E 171 | | color. | | E 172 | | Drucktinte | | Gelatina | | Kapselhülle | | Lacca | | | | Magnesii Stearas | | | | Povidonum K | 30 | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 84 Gélule(s) | 4501.01 | 4883.85 | B | LS | Oui |
|
|
